Immunology and Microbiology
Glycoprotein
100%
Arenaviridae
59%
Virus
57%
Human Immunodeficiency Virus 1
48%
Peptides
43%
Membrane Fusion
41%
Viral Envelope
39%
Gel Permeation Chromatography
37%
Hemorrhagic Fever
25%
Neutralization
20%
Virion
17%
Arenavirus
14%
Virus Neutralization
12%
Gp41
11%
Cell Line
11%
Monoclonal Antibody
11%
Cell Fusion
11%
Immunogenicity
11%
Feline Leukemia Virus
11%
Amino Acid
10%
T Cell
10%
Guinea Pig
9%
Revertant
9%
Human Immunodeficiency Virus
9%
Alanine
8%
Cell Surface
8%
Neutralizing Antibody
8%
Lassa Virus
8%
QS21
7%
Reverse Transcriptase
7%
Herpesviridae
7%
HIV Vaccine
7%
Cell Culture
7%
Antiviral Activity
6%
Host Cell
6%
Viral Disease
6%
Binding Antibody
5%
Adjuvant
5%
Hepatitis C Virus
5%
Virus Vaccine
5%
Mutagenesis
5%
Amino Terminal Sequence
5%
Receptor Binding
5%
Solution and Solubility
5%
Cell Membrane
5%
Epitope
5%
Morphogenesis
5%
Precursor
5%
Biochemistry, Genetics and Molecular Biology
Glycoprotein
75%
Membrane Fusion
40%
Virus Envelope
36%
Signal Peptide
33%
Arenaviridae
24%
Gp41
18%
Human Immunodeficiency Virus 1
18%
Dihydrofolate Reductase
14%
Genetics
12%
Small Molecule
11%
Messenger RNA
11%
Alanine
10%
Ectodomain
10%
Amino Acids
10%
Human Immunodeficiency Virus
9%
Mutagenesis
9%
C-Terminus
9%
Binding Domain
7%
Heptad Repeat
7%
Hepatitis C Virus
7%
Molecular Cloning
7%
Chimeric Protein
7%
Monoclonal Antibody
6%
Methotrexate
6%
N-Terminus
6%
Helix Bundle
6%
Cell Membrane
5%
Lassa virus
5%
Nucleotide Sequence
5%
Pharmacology, Toxicology and Pharmaceutical Science
RNA Directed DNA Polymerase Inhibitor
17%
Antiviral Activity
16%
Arenaviridae
16%
Pyridone Derivative
15%
Human Immunodeficiency Virus 1
13%
Cell Culture
12%
Hemorrhagic Fever
11%
RNA Directed DNA Polymerase
11%
Lassa Virus
11%
Glycoprotein
10%
Signal Peptide
9%
HIV
7%
Microsphere
7%
Antivirus Agent
6%
Infection
5%
Amino Acid
5%
Diseases
5%
Machupo Virus
5%
Clinical Trial
5%
